Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have received a consensus rating of “Buy” from the eight research firms that are covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $282.63.
BDX has been the subject of a number of recent research reports. StockNews.com upgraded shares of Becton, Dickinson and Company from a “hold” rating to a “buy” rating in a research note on Thursday, August 8th. Evercore ISI increased their target price on Becton, Dickinson and Company from $286.00 to $290.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Raymond James cut their price target on Becton, Dickinson and Company from $275.00 to $270.00 and set an “outperform” rating on the stock in a research note on Friday, August 2nd. Citigroup raised Becton, Dickinson and Company from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $255.00 to $275.00 in a research report on Tuesday, October 1st. Finally, Stifel Nicolaus raised their target price on Becton, Dickinson and Company from $270.00 to $280.00 and gave the stock a “buy” rating in a research report on Friday, July 26th.
Get Our Latest Stock Analysis on Becton, Dickinson and Company
Institutional Investors Weigh In On Becton, Dickinson and Company
Becton, Dickinson and Company Stock Performance
NYSE:BDX opened at $238.22 on Monday. Becton, Dickinson and Company has a 52 week low of $218.75 and a 52 week high of $269.52. The company has a fifty day simple moving average of $236.66 and a two-hundred day simple moving average of $235.54. The company has a quick ratio of 1.36, a current ratio of 1.85 and a debt-to-equity ratio of 0.70. The company has a market cap of $68.85 billion, a price-to-earnings ratio of 52.47, a price-to-earnings-growth ratio of 1.92 and a beta of 0.42.
Becton, Dickinson and Company (NYSE:BDX – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $3.50 earnings per share for the quarter, topping the consensus estimate of $3.31 by $0.19. The company had revenue of $4.99 billion for the quarter, compared to the consensus estimate of $5.08 billion. Becton, Dickinson and Company had a return on equity of 14.49% and a net margin of 7.13%. Becton, Dickinson and Company’s revenue was up 2.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.96 EPS. As a group, equities analysts anticipate that Becton, Dickinson and Company will post 13.1 earnings per share for the current fiscal year.
Becton, Dickinson and Company Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Monday, September 30th. Shareholders of record on Monday, September 9th were given a dividend of $0.95 per share. This represents a $3.80 annualized dividend and a yield of 1.60%. The ex-dividend date of this dividend was Monday, September 9th. Becton, Dickinson and Company’s dividend payout ratio (DPR) is 83.70%.
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.
See Also
- Five stocks we like better than Becton, Dickinson and Company
- How to Evaluate a Stock Before BuyingÂ
- 3 Key Stocks to Ride China’s Stimulus-Driven Growth
- How to Invest in Blue Chip Stocks
- 3 Dividend Growth Stocks Set to Supercharge Your Portfolio
- What is the Euro STOXX 50 Index?
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
Receive News & Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related companies with MarketBeat.com's FREE daily email newsletter.